
Phillips Medisize to Present Evidence-Based Framework for High-Dose Subcutaneous Drug Delivery at the 2026 Parenteral Drug Association (PDA) Universe of Pre-Filled Syringes and Injection Devices Conference
<a href="https://news.google.com/rss/articles/CBMi4AJBVV95cUxPbEoxXy1ESjhITTI3Uk9ZQU1oa3dROV9taW8tM2hiX2tRTC0wbUZPOUNibWNBUmxVRWQ2c29DUHZnaVpKbi1MdlNzd0lzWk9aRUpUS0hmbldrcDBNbDFJWnU2Q09ocVVWbi03Q2JuWXAydy1aWk1IRy1iRmI2RTZLOExtNENSd01tVmNHQU1yRFoxVnlodmdFczVZOHdVQ3RWTXBIM2lMUzRJSThnVDBTbmJmTkMtVW4wTFBmOXRlWFk0WGtqUTdXVk4zUnllaXg1S3dXMkRKeUhrcFF3SEdnNE5wUjZnSDRVSkh0RG5SN1BDR0tPb1UtYTBkMF9UVW1Id3d0LVJrOXNBQ0RTTHRUZk5LcWNWWE5DNUdSX1Z3YUg3MHlHZWhzOWJ6X2M0UkxGcWY4MUczV3pUV3RiX01haGJ5T2xZNjM0TW02REF5Q01fRmhHOU5EZnlDc0tqNk5v?oc=5" target="_blank">Phillips Medisize to Present Evidence-Based Framework for High-Dose Subcutaneous Drug Delivery at the 2026 Parenteral Drug Association (PDA) Universe of Pre-Filled Syringes and Injection Devices Conference</a>&nbsp;&nbsp;<font color="#6f6f6f">BioSpace</font>

